BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 18323584)

  • 1. [Beneficial effects of Hartil on cardiovascular remodeling process in elderly and old patients with isolated systolic arterial hypertension].
    Kiphshidze N; Zubiashvili T; Chagunava K
    Georgian Med News; 2008 Jan; (154):7-13. PubMed ID: 18323584
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An 18-week, prospective, randomized, double-blind, multicenter study of amlodipine/ramipril combination versus amlodipine monotherapy in the treatment of hypertension: the assessment of combination therapy of amlodipine/ramipril (ATAR) study.
    Miranda RD; Mion D; Rocha JC; Kohlmann O; Gomes MA; Saraiva JF; Amodeo C; Filho BL
    Clin Ther; 2008 Sep; 30(9):1618-28. PubMed ID: 18840367
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reverse remodeling and improved function by antihypertensive treatment in hypertensive patients with coronary artery disease.
    Yui Y; Kodama K; Hirayama A; Nishio R; Iwanaga Y; Nonogi H; Haze K; Sumiyoshi T; Yui N; Hosoda S; Kawai C;
    J Hypertens; 2010 Jan; 28(1):178-85. PubMed ID: 19927011
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Left ventricular (LV) geometry and dipping state are determinants of LV mass reduction with angiotensin-converting enzyme inhibitor antihypertensive treatment.
    Aznaouridis KA; Vyssoulis GP; Karpanou EA; Marinakis AG; Barbetseas JD; Zervoudaki AI; Cokkinos DV; Stefanadis CI
    Blood Press Monit; 2007 Apr; 12(2):87-94. PubMed ID: 17353651
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Improvement in diastolic function in hypertensive patients with left ventricular hypertrophy with inhibitors of the angiotensin converting enzyme].
    Sagastagoitia JD; Morillas M; Martínez A; Lage E; Pallarés C; Ugartemendía C; Asín E; Barrios V; Julia J; Sánchez P; Calvo C; González J; Piña C; García-Barbal J; Arnau C
    Rev Clin Esp; 1998 Jan; 198(1):15-22. PubMed ID: 9580230
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of sulfhydryl and non-sulfhydryl angiotensin-converting enzyme inhibitors on endothelial function in essential hypertensive patients.
    Pasini AF; Garbin U; Nava MC; Stranieri C; Pellegrini M; Boccioletti V; Luchetta ML; Fabrizzi P; Lo Cascio V; Cominacini L
    Am J Hypertens; 2007 Apr; 20(4):443-50. PubMed ID: 17386354
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The PHARAO study: prevention of hypertension with the angiotensin-converting enzyme inhibitor ramipril in patients with high-normal blood pressure: a prospective, randomized, controlled prevention trial of the German Hypertension League.
    Lüders S; Schrader J; Berger J; Unger T; Zidek W; Böhm M; Middeke M; Motz W; Lübcke C; Gansz A; Brokamp L; Schmieder RE; Trenkwalder P; Haller H; Dominiak P;
    J Hypertens; 2008 Jul; 26(7):1487-96. PubMed ID: 18551027
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renal and cardiac effects of antihypertensive treatment with ramipril vs metoprolol in autosomal dominant polycystic kidney disease.
    Zeltner R; Poliak R; Stiasny B; Schmieder RE; Schulze BD
    Nephrol Dial Transplant; 2008 Feb; 23(2):573-9. PubMed ID: 17984104
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of ramipril on the glucose/insulin coefficient and the ventricular mass index in patients with light to moderate arterial hypertension].
    Germán Cardona-Muñoz E; Noriega-Arellano J; Hernández-Chávez A; López-Alvarado A; González-Ortiz M; Martínez-Abundis E; Delgado Hurtado JM; Ramos-Remus C; Gamez-Nava I; Ayub-Ayala M
    Arch Cardiol Mex; 2003; 73(1):24-30. PubMed ID: 12820491
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased vascular compliance/decreased cardiovascular risk: what the studies tell us.
    Frishman WH
    Heart Dis; 2000; 2(5):384-8. PubMed ID: 11728287
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Ramipril effects on 24 hour profile of blood pressure in patients with mild and moderate hypertension].
    Kukushkin SK; Lebedev AV; Manoshkina EM; Shamarin VM
    Ter Arkh; 1998; 70(9):69-71. PubMed ID: 9821232
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanical vs intrinsic components in the improvement of brachial arterial compliance. Comparison of the effects of atenolol versus ramipril in hypertensive patients.
    Armentano RL; Graf S; Ramírez AJ; Espinosa JD; Brandani L; Baglivo H; Sánchez R
    Medicina (B Aires); 2001; 61(5 Pt 1):535-40. PubMed ID: 11721319
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical effectiveness of and tolerance to ramipril in the treatment of essential arterial hypertension phase 1 and 2. Results of a multicenter study].
    Fasce E; Román O; Zárate H; Prat H
    Rev Med Chil; 1997 Jan; 125(1):23-9. PubMed ID: 9336065
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety and tolerability of ramipril 10 mg in patients at high risk of cardiovascular events: an observational study.
    Hathial M
    Indian Heart J; 2008; 60(3):200-4. PubMed ID: 19240307
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of ramipril on left ventricular mass in normotensive hemodialysis patients.
    Yu WC; Lin YP; Lin IF; Chuang SY; Chen CH
    Am J Kidney Dis; 2006 Mar; 47(3):478-84. PubMed ID: 16490627
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of sustained-release-L-arginine formulation on blood pressure and vascular compliance in 29 healthy individuals.
    Miller AL
    Altern Med Rev; 2006 Mar; 11(1):23-9. PubMed ID: 16597191
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of a fixed-dose ACE inhibitor-diuretic combination on ambulatory blood pressure and arterial properties in isolated systolic hypertension.
    Ferguson JM; Minas J; Siapantas S; Komesaroff PA; Sudhir K
    J Cardiovasc Pharmacol; 2008 Jun; 51(6):590-5. PubMed ID: 18520951
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and tolerability of two formulations of ramipril in Korean adults with mild to moderate essential hypertension: an 8-week, multicenter, prospective, randomized, open-label, parallel-group noninferiority trial.
    Kim SH; Chung WY; Zo JH; Kim MA; Chang HJ; Cho YS; Youn TJ; Chae IH; Choi DJ; Gwak JJ; Lee HY; Park JS; Kang HJ; Kim YJ; Kim HS
    Clin Ther; 2009 May; 31(5):988-98. PubMed ID: 19539099
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of ramipril therapy on cognitive functions in cases of mild to moderate essential hypertension.
    Qureshi N; Babbar R
    Indian J Physiol Pharmacol; 2007; 51(1):40-8. PubMed ID: 17877291
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Utility of semiautomatic clinic and 24-h ambulatory blood pressure measurements to evaluate combination therapy: the Ramipril-Hydrochlorothiazide Hypertension trial.
    White WB; Cleveland JM; Rolleri RL;
    J Hum Hypertens; 2008 Aug; 22(8):559-68. PubMed ID: 18463672
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.